Enzate is a potent oral androgen receptor inhibitor used in the treatment of prostate cancer. It works by blocking the effects of androgens (male hormones), which fuel the growth of prostate cancer cells.

Strength:

• Enzate 40mg capsules

Therapeutic Indications:

• Metastatic Castration-Resistant Prostate Cancer (mCRPC)

• Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC)

• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Mechanism of Action:
Enzalutamide competitively inhibits androgen binding to androgen receptors, prevents nuclear translocation of the activated receptor, and blocks DNA binding — thereby suppressing cancer cell proliferation.

Key Features:

• Oral, once-daily administration

• Manufactured under GMP-certified conditions

• High bioavailability and efficacy

• Improves survival and disease control

• Suitable for use with or without corticosteroids

Packaging:

• Blister Packing contains 28 Capsules

Storage:
Store below 30°C. Protect from moisture and light. Keep out of reach of children.

Note: Prescription-only medicine. To be used under the supervision of an oncologist or medical practitioner.